Showing results (221-230 of 2,280) with videos related to

Sort By:
Pageof 228
HIV Medicine|July 9, 2004
A randomized study investigating the efficacy and safety of amprenavir in combination with low-dose ritonavir in protease inhibitor-experienced HIV-infected adultsF Pulido, C Katlama, M Marquez, et al.
HIV Medicine|July 14, 2005
The role of diet, exercise and smoking in dyslipidaemia in HIV-infected patients with lipodystrophyM Shah, K Tierney, B Adams-Huet, et al.
HIV Medicine|March 12, 2004
Differential CD4 T-cell response in HIV-1-infected patients using protease inhibitor-based or nevirapine-based highly active antiretroviral therapyF van Leth, F W N M Wit, P Reiss, et al.
HIV Medicine|March 12, 2004
Nevirapine- versus efavirenz-based highly active antiretroviral therapy regimens in antiretroviral-naïve patients with advanced HIV infectionW Manosuthi, S Sungkanuparph, A Vibhagool, et al.
HIV Medicine|March 12, 2004
Lung cancer in patients with HIV infection: is it AIDS-related?M Burke, A Furman, M Hoffman, et al.
HIV Medicine|January 27, 2005
Hydroxychloroquine, hydroxyurea and didanosine as initial therapy for HIV-infected patients with low viral load: safety, efficacy and resistance profile after 144 weeksN I Paton, J Aboulhab
HIV Medicine|January 27, 2005
Chlamydia pneumoniae infection in HIV-positive patients: prevalence and relationship with lipid profileG Tositti, M Rassu, P Fabris, et al.
HIV Medicine|January 27, 2005
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patientsU H Iloeje, Y Yuan, G L'italien, et al.
HIV Medicine|September 18, 2008
Pregnancy may be followed by an inflexion of the immune reconstitution in HIV-infected women who receive antiretroviral drugs before conceptionV Le Moing, A Taïeb, P Longuet, et al.
HIV Medicine|September 18, 2008
Pharmacokinetics of new 625 mg nelfinavir formulation during pregnancy and postpartumJ S Read, B M Best, A M Stek, et al.
Pageof 228